Live Breaking News & Updates on Stoke therapeutics

Stay informed with the latest breaking news from Stoke therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Stoke therapeutics and stay connected to the pulse of your community

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 4.4%

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report)’s share price traded down 4.4% during trading on Monday . The company traded as low as $11.36 and last traded at $11.52. 569,902 shares changed hands during trading, a decline of 41% from the average session volume of 971,281 shares. The stock had previously closed at $12.05. […]

United-states , Jonathan-allan , Sg-americas-securities , Stoke-therapeutics-inc , Mirae-asset-global-investments-co , Stoke-therapeutics-company-profile , Canaccord-genuity-group , Nasdaq , Sherbrooke-park-advisers , York-mellon-corp , Cantor-fitzgerald , Jpmorgan-chase-co

Stoke Therapeutics (NASDAQ:STOK) Trading 4.9% Higher

Stoke Therapeutics (NASDAQ:STOK) Trading 4.9% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Barry-ticho , Jpmorgan-chase-co , Nasdaq , Capital-partners , Stoke-therapeutics-company-profile , Stoke-therapeutics-inc , Securities-exchange-commission , Needham-company , Canaccord-genuity-group , Stoke-therapeutics , Get-free-report

Stoke Therapeutics (NASDAQ:STOK) Trading 4.9% Higher

Stoke Therapeutics (NASDAQ:STOK) Trading 4.9% Higher
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Stephenj-tulipano , Barry-ticho , Sherbrooke-park-advisers , Nasdaq , Dorsey-whitney-trust , Sg-americas-securities , Cantor-fitzgerald , Stoke-therapeutics-inc , Securities-exchange-commission , Corton-capital-inc

Recursion, Canaan, Metsera and more—Chutes & Ladders

Recursion, Canaan, Metsera and more—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , Italy , Utah , United-states , Italian , British , Le-goff , Cytosite-biopharma , Najat-khan , Corinne-le-goff

Stoke Therapeutics (NASDAQ:STOK) Trading 4.5% Higher

Stoke Therapeutics (NASDAQ:STOK) Trading 4.5% Higher
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hong-kong , United-states , Barry-ticho , Dorsey-whitney-trust , Securities-exchange-commission , Hong-kong-ltd , Jpmorgan-chase-co , Stoke-therapeutics-inc , Canaccord-genuity-group , Ensign-peak-advisors-inc , Nasdaq , Great-west-life-assurance-co

Stoke Therapeutics (NASDAQ:STOK) Trading 4.5% Higher

Stoke Therapeutics (NASDAQ:STOK) Trading 4.5% Higher
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Hong-kong , American , Stephenj-tulipano , Jonathan-allan , York-mellon-corp , Ensign-peak-advisors-inc , American-international-group-inc , Securities-exchange-commission , Hong-kong-ltd , Cantor-fitzgerald , Great-west-life-assurance-co

Stoke Therapeutics' (STOK) Buy Rating Reaffirmed at Needham & Company LLC

Stoke Therapeutics (NASDAQ:STOK – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a report released on Thursday, Benzinga reports. They presently have a $22.00 price objective on the stock. Needham & Company LLC’s target price indicates a potential upside of 72.41% from the company’s current […]

Hong-kong , United-states , Jonathan-allan , Stoke-therapeutics-inc , Canaccord-genuity-group , Securities-exchange-commission , Jpmorgan-chase-co , Great-west-life-assurance-co , Dorsey-whitney-trust , Ensign-peak-advisors-inc , Hong-kong-ltd , Stoke-therapeutics-company-profile

Stoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%

Stoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Ohio , Jonathan-allan , Stephenj-tulipano , Needham-company , Stoke-therapeutics-inc , Securities-exchange-commission , Cantor-fitzgerald , Jpmorgan-chase-co , Mirae-asset-global-investments-co , Corton-capital-inc , Nasdaq

Stoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%

Stoke Therapeutics (NASDAQ:STOK) Shares Up 5.1%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Jonathan-allan , Barry-ticho , Canaccord-genuity-group , Corton-capital-inc , Nasdaq , Needham-company , Mirae-asset-global-investments-co , Capital-partners , Stoke-therapeutics-inc , Jpmorgan-chase-co